JAK2 c.2949G>T ;(p.L983F)

Variant ID: 9-5090801-G-T

NM_004972.3(JAK2):c.2949G>T;(p.L983F)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Molecular dissection of Janus kinases as drug targets for inflammatory diseases.

Frontiers In Immunology
Kwon, Sunghark S
Publication Date: 2022

Variant appearance in text: JAK2: L983F
PubMed Link: 36569926
Variant Present in the following documents:
  • Main text
  • fimmu-13-1075192.pdf
View BVdb publication page



Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML.

Blood Advances
Azhar, Mohammad M; Kincaid, Zachary Z; Kesarwani, Meenu M; Menke, Jacob J; Sweiterman, Joshua J; Ansari, Sekhu S; Reaves, Angela A; Ahmed, Arhama A; Shahzad, Rammsha R; Khan, Areeba A; Syed, Nuha N; Amir, Noor N; Wunderlich, Mark M; Latif, Tahir T; Seibel, William L WL; Azam, Mohammad M
Publication Date: 2022-08-31

Variant appearance in text: JAK2: L983F
PubMed Link: 36044389
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia.

International Journal Of Molecular Sciences
Jędraszek, Krzysztof K; Malczewska, Marta M; Parysek-Wójcik, Karolina K; Lejman, Monika M
Publication Date: 2022-03-12

Variant appearance in text: JAK2: L983F
PubMed Link: 35328487
Variant Present in the following documents:
  • Main text
  • ijms-23-03067.pdf
View BVdb publication page



Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia.

Npj Precision Oncology
Downes, Charlotte E J CEJ; McClure, Barbara J BJ; Bruning, John B JB; Page, Elyse E; Breen, James J; Rehn, Jacqueline J; Yeung, David T DT; White, Deborah L DL
Publication Date: 2021-08-10

Variant appearance in text: JAK2: L983F
PubMed Link: 34376782
Variant Present in the following documents:
  • Main text
  • 41698_2021_215_MOESM1_ESM.pdf
  • 41698_2021_Article_215.pdf
View BVdb publication page



Targeting substrate-site in Jak2 kinase prevents emergence of genetic resistance.

Scientific Reports
Kesarwani, Meenu M; Huber, Erika E; Kincaid, Zachary Z; Evelyn, Chris R CR; Biesiada, Jacek J; Rance, Mark M; Thapa, Mahendra B MB; Shah, Neil P NP; Meller, Jarek J; Zheng, Yi Y; Azam, Mohammad M
Publication Date: 2015-09-30

Variant appearance in text: JAK2: L983F
PubMed Link: 26419724
Variant Present in the following documents:
  • Main text
  • srep14538.pdf
View BVdb publication page